Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06550050 · ClinicalTrials.gov registry record
Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
A clinical trial of Oral Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06550050: Recruiting study of Oral Cancer, sponsored by M.D. Anderson Cancer Center.
NCT06550050 is a study of Oral Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,000 participants, above the 154-participant average among 17 other Oral Cancer trials with a reported enrollment target (549% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06550050, a study of Oral Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will employ serial assessments of tissue biopsy and additional biomarkers that reflect burden of disease and predict treatment response. Patients enrolled on this study will be given the option to provide biological samples before, during, and after treatment, as well as functional outcomes of treatment response. These samples will be utilized to develop and validate prognostic and predictive biomarkers for patients undergoing targeted therapy, immunotherapy, surgery, chemotherapy, and/or radiotherapy.
Primary Outcome
The MDASI-HN is a patient-reported outcome questionnaire designed to measure the severity or burden of systemic and head- and neck-specific symptoms and their interference with or effect on patients' daily functioning (Rosenthal, Mendoza et al. 2007, Cleeland 2016). This 28-item multi-symptom inventory is rated according to the last 24 hours at their worst, with 0 being symptoms not present and 10 being as bad as the patient can imagine. Cronbach alpha reliability ranges from 0.72 to 0.92.
Conditions Studied
Interventions
- BEHAVIORAL Radiation
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-10-31 |
| Est. Completion | 2066-12-31 |
What NCT06550050 shows while recruiting
NCT06550050 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 154-participant average among 17 other Oral Cancer trials with a reported enrollment target (549% higher).
The record links to 1 condition, with Oral Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radiation is the first listed.
NCT06550050 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06550050 about?
NCT06550050 is a clinical study titled "Clinical and Molecular Features of Oral Premalignancy and Oral Cancer". Investigators will employ serial assessments of tissue biopsy and additional biomarkers that reflect burden of disease and predict treatment response. Patients enrolled on this study will be given the option to provide biological samples before, during, and after treatment, as well as functional out...
What is the current status of trial NCT06550050?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2024-10-31. Estimated completion is 2066-12-31.
What conditions does trial NCT06550050 study?
This clinical trial studies the following conditions: Oral Cancer.
What interventions are being tested in trial NCT06550050?
The interventions under investigation include: Radiation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06550050?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06550050 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oral Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06550050's enrollment target sits among peer trials
1,000 2nd of 17 the highest of 17 other Oral Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oral Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial
RECRUITING · NA
-
Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery
RECRUITING
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
RECRUITING · NA
-
Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
RECRUITING · NA
-
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI